+41 61 225 46 00
Ridgeline, Versant’s newest Discovery Engine based in Switzerland, became operational in 2017 and has deployed resources on several programs derived from European academic institutes. Ridgeline’s central European location gives it access to both strong academic research as well as large pharmaceutical partners.
Ridgeline employs a team of accomplished industry R&D veterans, with laboratory facilities located in the Basel Technology Park. Ridgeline already has created and launched three companies with breakthrough platforms for drug discovery.